Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of JP-1366 for gastric ulcer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcer

Drugs mentioned

• JP-1366

Snippet

Sponsor: Onconic Therapeutics Inc. | Conditions: Gastric Ulcer | Phase 3 | Status: COMPLETED